Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma-Reference-Cited by-同舟云学术

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma

Published:2018-12 Issue:6 Volume:2 Page:e160
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Herfarth Klaus,Borchmann Peter,Schnaidt Sven,Hohloch Karin,Budach Volker,Engelhard Marianne,Viardot Andreas,Engenhart-Cabillic Rita,Keller Ulrich,Reinartz Gabriele,Eich Hans-Theodor,Witzens-Harig Mathias,Hess Clemens F.,Dörken Bernd,Dürig Jan,Wiegel Thomas,Hiddemann Wolfgang,Hoster Eva,Pott Christiane,Dreyling Martin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference37 articles.

1. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Dreyling;Ann Oncol,2017

2. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University;Mac Manus;J Clin Oncol,1996

3. Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-fruhe Stadien;Stuschke;Cancer,1997

4. Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma;Rambaldi;Blood,2002

5. Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab;Galimberti;Bone Marrow Transplant,2003

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in early-stage follicular lymphoma: TROG99.03;2024-08-11

2. Diagnosis, management and follow‐up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance;Internal Medicine Journal;2024-08

3. Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial;The Lancet Haematology;2024-07

4. B-cell non-Hodgkin lymphomas;The Lancet;2024-05

5. Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations;Cancer/Radiothérapie;2024-02